Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2006
02/08/2006CN1241010C Hand-held automatic refractometer
02/08/2006CN1241008C Milking device for laboratory animals
02/08/2006CN1240836C Transforming growth factor alpha HI
02/08/2006CN1240685C Production method and use for dichloro quinolinic acid artificial hapten, artificial antigen and specific antibody
02/08/2006CN1240460C Blood processing procedures with related sensing procedures
02/08/2006CN1240372C Incorporation of exogenous lactic acid bacteria into oral microflora
02/08/2006CN1240341C Non-invasive measurement of skin bilirubin level
02/07/2006US6996497 Method of evaluating logs to predict properties of lumber or veneer produced from the logs
02/07/2006US6996478 Multiple sensing system and device
02/07/2006US6996477 Computational subtraction method
02/07/2006US6996476 Methods and systems for gene expression array analysis
02/07/2006US6996474 Automated method for identifying related biomolecular sequences
02/07/2006US6996473 Method for screening and producing compound libraries
02/07/2006US6996472 Drift compensation method for fingerprint spectra
02/07/2006US6995845 Methods for detecting analytes using optical discs and optical disc readers
02/07/2006US6995841 Pulsed-multiline excitation for color-blind fluorescence detection
02/07/2006US6995835 measuring concentration of hemoglobin, bilirubin, dehydrobilirubin, lipids, methylene blue and crosslinked hemoglobin, using infared radiation, then analyzing absorption; spectrum analysis; spectrophotometry
02/07/2006US6995834 Method for analyzing impurities in a silicon substrate and apparatus for decomposing a silicon substrate through vapor-phase reaction
02/07/2006US6995348 Optical detection system including semiconductor element
02/07/2006US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C
02/07/2006US6995298 rodents which expresses transgenes integrated into its genome, wherein the genes comprises DNA codes for proteins having amino acid replacements so that the mammal has platelets with reduced or absent phosphorylation; genetic engineering
02/07/2006US6995284 Synthesis of selective androgen receptor modulators
02/07/2006US6995274 Cyanine dyes
02/07/2006US6995262 Use of acylsulfonamido-substituted polymethine dyes as fluorescene dyes and/or markers
02/07/2006US6995259 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass
02/07/2006US6995257 Notch3 gene and the corresponding protein, which are involved in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy); probes and primers; mutations in gene that indicate risk of developing CADASIL
02/07/2006US6995254 Given sequences; vectors; host cells; use as a drug target to screen for novel antibiotics as FAB I is involved in bacterial fatty acid biosynthesis
02/07/2006US6995243 A molecule of the antigen binding portion phosphoryalated at residue Ser211 or Ser226 of a specific amino acid sequence; determining glucocorticoid receptors in cells from human glucocorticoid responsive tissue; agonist screening
02/07/2006US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries
02/07/2006US6995240 Treatment of inflammatory disease
02/07/2006US6995236 Sphingomyelin detecting probe
02/07/2006US6995152 Diagnosis and treatment of human kidney diseases
02/07/2006US6995134 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics
02/07/2006US6995023 Labeling proteins with dyes that are insoluble or only sparingly soluble in water
02/07/2006US6995022 Drug screening a candidate for drug development; metabolizing with biological material enzyme, forming metabolites, separating by ultrafiltration membrane pore sizes, mass spectrometry analysis; permselectivity; enzyme assays; kits
02/07/2006US6995021 Method and apparatus for qualitative and quantitative detection of analytes
02/07/2006US6995020 Pressure cooking sample with ammonia, ethanol in sodium borohydride; pretreatment of FISH analysis, reduce the tissue autofluorescence for improving the detection of mRNA transcripts in paraffin-embedded tissue
02/07/2006US6995018 Complex formed by N-linked glycoproteins (SIBLINGS)and Factor H
02/07/2006US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases
02/07/2006US6994984 Kits for monitoring blood coagulation and stabilty of bodily fluids
02/07/2006US6994983 Determining asprin dosage by measuring concentration of metabolitein urine using antbody and color indicator; side effect reduction; drug resistance; kits
02/07/2006US6994982 Isolating biological modulators from biodiverse gene fragment libraries
02/07/2006US6994981 Modulators of paraptosis and related methods
02/07/2006US6994980 Chemiluminescent compounds and use thereof
02/07/2006US6994979 Drug screening for compounds that modulate the function of anti-apoptotic protein Bcl-2 to induce apoptosis; identifying antitumor agents
02/07/2006US6994978 Human osteoclast derived cathepsin
02/07/2006US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex
02/07/2006US6994976 Monoclonal antibody that binds to TR3 (also known as Apo-3, DR3, LARD, Tramp, and WSL-1), a tumor necrosis factor receptor (TNFR) superfamily member of cell-surface antigens, and inhibits the proliferation of activated lymphocytes expressing TR3
02/07/2006US6994975 Expression and purification of ATM protein using vaccinia virus
02/07/2006US6994974 Drug screening for a substance that inhibits endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide from binding to amyloid-beta peptide; neurodegenerative disorders
02/07/2006US6994973 Using orthocresolphthalein complex test strip to determine calcium and magnesium concentrations in aqueous samples; colorimetric analysis; water potability; water treatment
02/07/2006US6994971 does not require reattachment of the target sequence to a solid support to perform the second step, does not require Polymerase Chain Reaction (PCR), highly quantitative, uses readily available laboratory equipment; magnetic and nonmagnetic beads
02/07/2006US6994966 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
02/07/2006US6994965 Visual comfirmation of similarity score calculated from base sequences of probe biopolymers represented by, e.g., square patterns having varying depths in color; accuracy; side by side display for comparison; unexpected hybridization; microarrays
02/07/2006US6994964 Macromolecular arrays on polymeric brushes and methods for preparing the same
02/07/2006US6994957 Using nucleic acid
02/07/2006US6994956 combining with radiolabelled substrate, adding phase-partition scintillation fluid, then incubating within single vessel comprising multiwell plates; for screening compounds for treatment of diabetes, obesity, cardiovascular disease, and cancer
02/07/2006US6994955 Complex of lipoprotein and hemoglobulin; analyzing
02/07/2006US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
02/07/2006US6994858 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition
02/07/2006US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
02/07/2006US6994840 Kit for radiolabeling ligands with yttrium-90
02/07/2006US6994827 Shaft driven stirrers; connecting chemical reactors; fluid flow; biosynthesis
02/07/2006US6994825 Analyte measurement kit
02/07/2006US6994781 Medical system, method and apparatus employing MEMS
02/07/2006US6994777 Chemical sensors utilizing conducting polymer compositions
02/07/2006US6994671 Apparatus and method for screening, olfactory mucosa stimulating compound found by the screening method, and therapeutic apparatus and electrode section for measurement
02/07/2006US6993988 Locking clips for retaining parallel elongated members
02/07/2006US6993984 Method and apparatus for supplying sample sand from a mixing machine to a sand-property-measuring apparatus
02/07/2006US6993964 Method of determining a modulus of elasticity of a moving web material
02/07/2006CA2408642C Method and device for the monitoring of gases
02/07/2006CA2397557C Extrasomatic diagnostics
02/07/2006CA2360595C Hybrid film type sensor
02/07/2006CA2247919C Termite detection system
02/07/2006CA2092603C Tissue fixative and method
02/06/2006CA2514788A1 System and method for the detection of bluestain and rot on wood
02/03/2006CA2514010A1 Assay
02/02/2006WO2006012646A2 Amacr cancer markers
02/02/2006WO2006012614A2 Fabrication methods and multifunctional substrate materials for chemical and biological analysis in microfluidic systems
02/02/2006WO2006012588A2 Methods and devices for diagnosis of appendicitis
02/02/2006WO2006012507A2 Methods and compositions for risk stratification
02/02/2006WO2006012486A2 Immunoassay assembly and methods of use
02/02/2006WO2006012472A1 Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
02/02/2006WO2006012451A2 Compositions and methods of use for mgd-csf in disease treatment
02/02/2006WO2006012413A1 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
02/02/2006WO2006012402A1 Use of adiponectin to diagnose and treat malignancy
02/02/2006WO2006012309A1 Inducible inactivation of synaptic transmission
02/02/2006WO2006012304A2 Increasing life span by modulation of smek
02/02/2006WO2006012259A1 Methods involving micromosal prostaglandin e2 synthase
02/02/2006WO2006012222A2 Methods of treating smooth muscle cell disorders
02/02/2006WO2006012154A1 A method for detecting reactive metabolites using stable-isotope trapping and mass spectroscopy
02/02/2006WO2006012118A1 System and method for rheological characterization of granular materials
02/02/2006WO2006011920A1 Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
02/02/2006WO2006011919A1 Method and device for detecting feline immunodeficiency virus
02/02/2006WO2006011917A1 Method and device for detecting feline immunodeficiency virus
02/02/2006WO2006011589A1 Method of preparing artificial gene population and artificial protein population by random polymerization of motif sequences of multiple types
02/02/2006WO2006011491A1 Plasmid vector, transgenic animal, method of screening drug and drug
02/02/2006WO2006011393A1 Analysis device, analysis disk, and analysis system with the device and the disk
02/02/2006WO2006011352A1 Peptide or protein phosphorylation analyzer, phosphorylation discrimination program, and recording medium for the program
02/02/2006WO2006010907A1 Dual chamber gas sampling device with indicators